Steady information monitoring and AI-assisted predictive drugs “higher” for diabetes care, says clinic

Distant steady information monitoring – a personalised, tech-focused method to diabetes administration employed by one Dubai-based specialist clinic – continues to exhibit optimistic leads to its sufferers, it has been confirmed.

Six months since the discharge of its first report showcasing preliminary outcomes of its care mannequin, GluCare Built-in Diabetes Middle has now printed a second set of scientific outcomes revealing additional discount of haemoglobin A1c (HbA1c) ranges in its sufferers.

Showing within the journal Diabetes Administration, the clinic’s newest outcomes present that these present process therapy decreased their HbA1c ranges by a median of two.14% over 90 days.

In April, outcomes confirmed a median HbA1c discount of 1.7%.

This newest information consists of sufferers assessed within the first report in addition to new sufferers, the corporate confirmed to MobiHealthNews.

HbA1c – or glycated haemoglobin – is used to evaluate common blood sugar ranges over a interval of weeks or months. The upper the HbA1c, the better the chance of growing diabetes-related problems.

“GluCare has demonstrated that working towards steady information monitoring, alongside AI-[artificial intelligence] assisted predictive drugs, is vastly higher in bettering the well being of these with the situation compared to episodical, and sometimes symptomatic care,” the corporate stated in an announcement.


In an electronic mail to MobiHealthNews, GluCare co-founder and managing director, Dr Ihsan Almarzooqi defined that adopting a clear method to reporting information is essential in bettering the healthcare panorama within the Center East and North Africa (MENA) area.

“We predict that reporting scientific outcomes transparently, whether or not good or dangerous, is crucial to the adoption of a value-based reimbursement construction within the MENA area, which is one thing we’ve got been lobbying since our inception,” he stated. “It holds suppliers accountable, saves the system cash, and most significantly, improves affected person outcomes and gives them with alternative on the place to hunt care.”

As of figures final up to date in 2020, the Worldwide Diabetes Federation (IDF) estimates that round 55 million individuals within the MENA area have diabetes; a determine that may rise to a projected 108 million by 2045.

Within the United Arab Emirates (UAE), the IDF states that the present prevalence of diabetes amongst adults is roughly 15.4% (estimated from a inhabitants of seven,925,700 in its figures).


GluCare – which debuted within the UAE in September 2020 – describes itself because the “world’s first healthcare supplier to make use of built-in steady information monitoring” and the “area’s first healthcare supplier to make use of digital therapeutics (DTx)”.

Sufferers reportedly obtain a linked equipment, which features a wearable blood glucose monitor that collects information in real-time. In flip, it makes use of AI to establish particular person threat components.

“The usage of real-time information to grasp our affected person’s well being permits us to be extra current with them in-clinic and prescribe care extra successfully,” stated co-founder and chairman, Ali Hashemi. “In between visits, this system additionally permits us to remain linked with them and supply significant assist. Our know-how permits us to supply a extra human-centric method to diabetes care, one which works extraordinarily properly as highlighted by our outcomes.”

Those that have adopted this method to diabetes administration have additionally reportedly demonstrated different metabolic-related enhancements, resembling “a 39% discount in cardiovascular threat, 4.5% discount in weight, 17% discount in dangerous ldl cholesterol, 20% discount in uric acid and a 6.2% discount in irritation.”


“If we’re going to lastly influence the prices and outcomes related to diabetes administration at a world scale, then we have to have a look at your entire worth chain of diabetes, and never virtual-only options layered on prime of conventional care,” continued Hashemi. “Having the ability to launch our model-of-care in a rustic the place uncontrolled diabetes is so prevalent, and to show its effectiveness, is a blessing. 

“It foreshadows what is feasible for sufferers globally who’ve lengthy suffered with insufficient care and assist in a healthcare system that merely didn’t work for them.”

AlMarzooqi added: “[Our care model is] not solely efficient, but it surely vastly outperforms conventional fashions of care. We consider diabetes administration is prepared for disruption. As an entire, the prevailing established order on managing diabetics is solely not bettering outcomes and decreasing prices.”

Final month, GluCare grew to become the primary healthcare supplier exterior of the USA to be awarded full URAC accreditation in Distant Affected person Monitoring (RPM).

Supply hyperlink

What's your reaction?

In Love
Not Sure

You may also like

More in:Health

Leave a reply

Your email address will not be published. Required fields are marked *